SPARC announces retirement of Dr Chitturi Trinadha Rao - Senior Vice President, Drug Discovery
Mumbai: Sun Pharma Advanced Research Company Limited (SPARC) has announced that Dr Chitturi Trinadha Rao – Senior Vice President, Drug Discovery, has retired from the Company.
"We would like to inform about that Dr Chitturi Trinadha Rao – Senior Vice President, Drug Discovery, retired from the Company with effect from closing of business hours of October 31, 2023," the Company informed in a BSE filing.
Dr Rao carries over 22 years of experience in synthetic organic/ medicinal chemistry together at SPIL & SPARC Ltd. Prior to joining SUN, Dr Rao was associated with GlaxoSmithkline Pharmaceuticals Ltd. Thane, as Group Leader in Chemistry R&D. for about 4 years.
Read also: SPARC concludes enrolment in global Phase 2 study of Vodobatinib in early Parkinson's disease
SPARC is a clinical stage bio-pharmaceutical company. SPARC was formed in 2007 through a demerger from SUN PHARMA.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd